|
AP4E1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.208360E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.583200E-01 |
| Normal-vs-Stage2 |
4.184000E-02 |
| Normal-vs-Stage3 |
1.270820E-01 |
| Normal-vs-Stage4 |
7.201600E-03 |
| Stage1-vs-Stage2 |
1.006040E-01 |
| Stage1-vs-Stage3 |
2.761000E-01 |
| Stage1-vs-Stage4 |
1.201700E-02 |
| Stage2-vs-Stage3 |
4.429600E-01 |
| Stage2-vs-Stage4 |
7.970600E-01 |
| Stage3-vs-Stage4 |
2.121400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.157200E-01 |
| Normal-vs-AfricanAmerican |
3.560600E-01 |
| Normal-vs-Asian |
2.901400E-01 |
| Caucasian-vs-AfricanAmerican |
9.077600E-01 |
| Caucasian-vs-Asian |
8.324600E-01 |
| AfricanAmerican-vs-Asian |
9.669400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.420300E-02 |
| Normal-vs-Female |
1.924390E-01 |
| Male-vs-Female |
4.003800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.342600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.524000E-02 |
| Normal-vs-Age(61-80Yrs) |
4.794400E-02 |
| Normal-vs-Age(81-100Yrs) |
7.175900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.890000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.501900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.063600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.619800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.859200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.550000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.705800E-01 |
| Classical-VS-Follicular |
2.006700E-04 |
| Classical-VS-Other |
2.024800E-01 |
| Classical-VS-Normal |
7.890200E-01 |
| Tall-VS-Follicular |
1.034230E-01 |
| Tall-VS-Other |
3.821000E-01 |
| Tall-VS-Normal |
4.792000E-01 |
| Follicular-VS-Other |
9.793000E-01 |
| Follicular-VS-Normal |
3.178500E-03 |
| Other-VS-Normal |
1.117440E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.864450E-02 |
| Normal-vs-N1 |
1.540980E-01 |
| N0-vs-N1 |
8.156800E-01 |
|
|
